Translational Medicine

  • Develop translational medicine strategy that includes relevant preclinical disease and safety models, biomarker identification and selection, and precision medicine strategies that can form the basis for a pre-IND meeting with the FDA
  • Design and execute clinical first-in-human, proof-of-principle and proof-of-concept studies, including writing protocols, CRO selection and management, and medical safety monitoring
  • Identify, recruit and manage KOLs and scientific advisory board meetings
  • Therapeutic areas: regenerative medicine, neurology/neurodegeneration, cardiovascular disease, immunology, hematology and oncology